Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicamenta AS

Division of Glenmark Pharmaceuticals Ltd.

Latest From Medicamenta AS

Glenmark acquires seven products from Actavis in Poland

Glenmark Pharmaceuticals has acquired seven pharmaceutical brands in Poland from Actavis and its Polish affiliate, Biovena, for an undisclosed sum. The acquisition, which has been routed through Glenmark's Czech subsidiary, Medicamenta, is expected to kick-start the Indian company’s entry into Poland.

Slovakia Companies

Deals Shaping the Medical Industry (5/07)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Eastern Europe
        • Czech Republic
  • Parent & Subsidiaries
  • Glenmark Pharmaceuticals Ltd.
  • Senior Management
  • Paul Wohanka, Chmn.
  • Contact Info
  • Medicamenta AS
    Phone: 420 234 714 340
    Belohorská 39
    Praha, 169 00
    Czech Republic